Keyword: Sprout Pharmaceuticals


Investors sue Valeant for shoddy Addyi marketing

When Valeant bought Sprout and its controversial female libido drug Addyi, it agreed to a marketing blitz that would bring royalties to Sprout's former shareholders. Valeant bungled the job, those former investors say. And they’re taking their gripes to court.